Advertisement

Supply Chain



Eli Lilly CFO Derica Rice is retiring in December 2017, ending a 27-year career with the global pharmaceutical giant.

Mylan faced a firestorm of criticism last year for the high price of EpiPens, which increased nearly 400 percent since 2004. Despite immense public scrutiny, a CMS rebate scandal and several federal hearings all spurred by the product's price, a…

The Food and Drug Administration has approved 21 new drugs so far in 2017, with several regulatory decisions set to be made this month, according to Zacks Investment Research.

Advertisement

Most Read

Advertisement
Advertisement